Sagaram, M.; Parthasarathy, R.; Condon, S.L.; Closson, C.F.; Kong, M.; Schwandt, M.L.; Jophlin, L.L.; Feng, W.; Barve, A.J.; Vatsalya, V.
Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. Int. J. Mol. Sci. 2022, 23, 5852.
https://doi.org/10.3390/ijms23105852
AMA Style
Sagaram M, Parthasarathy R, Condon SL, Closson CF, Kong M, Schwandt ML, Jophlin LL, Feng W, Barve AJ, Vatsalya V.
Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. International Journal of Molecular Sciences. 2022; 23(10):5852.
https://doi.org/10.3390/ijms23105852
Chicago/Turabian Style
Sagaram, Manasa, Ranganathan Parthasarathy, Sally L. Condon, Charles F. Closson, Maiying Kong, Melanie L. Schwandt, Loretta L. Jophlin, Wenke Feng, Ashutosh J. Barve, and Vatsalya Vatsalya.
2022. "Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis" International Journal of Molecular Sciences 23, no. 10: 5852.
https://doi.org/10.3390/ijms23105852
APA Style
Sagaram, M., Parthasarathy, R., Condon, S. L., Closson, C. F., Kong, M., Schwandt, M. L., Jophlin, L. L., Feng, W., Barve, A. J., & Vatsalya, V.
(2022). Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. International Journal of Molecular Sciences, 23(10), 5852.
https://doi.org/10.3390/ijms23105852
